851 related articles for article (PubMed ID: 26175357)
1. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
2. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
3. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
4. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
Schonmann Y; Bleich O; Matalon A; Yeshua H
Eur J Prev Cardiol; 2018 May; 25(8):870-880. PubMed ID: 29517367
[TBL] [Abstract][Full Text] [Related]
6. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
7. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
[TBL] [Abstract][Full Text] [Related]
9. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
Ko MJ; Kim YJ; Park CM; Lee SM; Lee WJ; Pencina MJ; Navar-Boggan AM; Park DW
Am Heart J; 2015 Sep; 170(3):598-605.e7. PubMed ID: 26385045
[TBL] [Abstract][Full Text] [Related]
10. Time to improve statin prescription guidelines in low-risk patients?
Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
[TBL] [Abstract][Full Text] [Related]
12. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
Echeverría G; Dussaillant C; Villarroel L; Rigotti A
J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136
[TBL] [Abstract][Full Text] [Related]
13. Population health impact of statin treatment in Canada.
Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
[TBL] [Abstract][Full Text] [Related]
14. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
[TBL] [Abstract][Full Text] [Related]
15. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
16. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in the Use of Statins in Community Practice.
Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
[TBL] [Abstract][Full Text] [Related]
18. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
19. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
Goyal A; Cooper HA; Aronow WS; Nagpal P; Yandrapalli S; Nabors CC; Frishman WH
Am J Med; 2018 Oct; 131(10):1234-1237. PubMed ID: 29928863
[TBL] [Abstract][Full Text] [Related]
20. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS
Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
